Recent studies have identified that the positive selection of CD24 selects for cancer stem cells in several cancers, including pancreatic cancer [9] colorectal cancer [10], liver [11], and ovarian cancer [12]. This evidence concerns the gene CD24 and pancreatic neoplasm.